Therapeutic strategies for spinal muscular atrophy: SMN and beyond
Spinal muscular atrophy (SMA) is a devastating neuromuscular disorder characterized by loss of motor neurons and muscle atrophy, generally presenting in childhood. SMA is caused by low levels of the survival motor neuron protein (SMN) due to inactivating mutations in the encoding gene SMN1. A second...
المؤلفون الرئيسيون: | Bowerman, M, Becker, C, Yáñez-Muñoz, R, Ning, K, Wood, M, Gillingwater, T, Talbot, K, UK SMA Research Consortium |
---|---|
التنسيق: | Journal article |
منشور في: |
Company of Biologists
2017
|
مواد مشابهة
-
Therapeutic strategies for spinal muscular atrophy: SMN and beyond
حسب: Bowerman, M, وآخرون
منشور في: (2017) -
Therapeutic strategies for spinal muscular atrophy: SMN and beyond
حسب: Melissa Bowerman, وآخرون
منشور في: (2017-08-01) -
Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
حسب: Winkelsas, AM, وآخرون
منشور في: (2021) -
Targeting the 5′ untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
حسب: Audrey M. Winkelsas, وآخرون
منشور في: (2021-03-01) -
SMN deficiency disrupts brain development in a mouse model of severe spinal muscular atrophy.
حسب: Wishart, T, وآخرون
منشور في: (2010)